Bath & Body Works (NYSE:BBWI – Get Free Report) issued an update on its fourth quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.700- for the period, compared to the consensus earnings per share estimate of 2.160. The company issued revenue guidance of -. Bath & Body Works also updated its FY 2025 guidance to 2.870- EPS.
Bath & Body Works Price Performance
NYSE:BBWI opened at $21.06 on Thursday. The stock’s 50 day simple moving average is $25.07 and its two-hundred day simple moving average is $28.34. Bath & Body Works has a 1 year low of $20.85 and a 1 year high of $41.87. The company has a market cap of $4.34 billion, a price-to-earnings ratio of 6.25, a PEG ratio of 0.86 and a beta of 1.53.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. As a group, analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.
Bath & Body Works Dividend Announcement
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on BBWI shares. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $26.00 target price on shares of Bath & Body Works in a research report on Monday, October 6th. Wall Street Zen lowered shares of Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Finally, UBS Group dropped their price target on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research note on Friday, August 29th. Ten research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $38.18.
Check Out Our Latest Stock Analysis on Bath & Body Works
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the stock. Sivia Capital Partners LLC acquired a new stake in shares of Bath & Body Works in the second quarter valued at about $306,000. Cerity Partners LLC boosted its stake in shares of Bath & Body Works by 14.6% during the second quarter. Cerity Partners LLC now owns 91,183 shares of the company’s stock valued at $2,732,000 after acquiring an additional 11,624 shares during the last quarter. Gabelli Funds LLC acquired a new stake in shares of Bath & Body Works during the 2nd quarter worth about $1,408,000. Gamco Investors INC. ET AL acquired a new position in Bath & Body Works in the 2nd quarter valued at $445,000. Finally, Jump Financial LLC purchased a new position in shares of Bath & Body Works during the 2nd quarter worth $2,722,000. 95.14% of the stock is owned by institutional investors and hedge funds.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Applied Materials: Up 40% in 2025 With Room to Run Long-Term
- Upcoming IPO Stock Lockup Period, Explained
- onsemi Places a $6 Billion Bet on Its Own Stock
- Stock Sentiment Analysis: How it Works
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
